Ticker name:TSHATaysha Gene Therapies, Inc.

Country: US-Sector: Healthcare, Industry: Biotechnology

Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.

Market Cap 1.4B

Last close 4.36$

Floor clearance 24.22%

Floor clearance (Past 30d)17.23%

Price Return

90d
-31.23%
YTD
-20.73%
1Y
2.11%
3Y
79.42%
5Y
-71.67%

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA139B549.04$
2MRNAModerna, Inc.103B258.38$
3REGNREGENERON PHARMACEUTICALS, INC.96B930.67$
4RVMDRevolution Medicines, Inc.43B199.7$
5GMABGENMAB A/S34B55.12$
6ROIVRoivant Sciences Ltd.28B38.23$
7UTHRUNITED THERAPEUTICS Corp26B608.49$
8INCYINCYTE CORP25B122.85$
9INSMINSMED Inc24B110$
10ALNYALNYLAM PHARMACEUTICALS, INC.22B161.08$
11EXELEXELIXIS, INC.18B72.75$
12ASNDAscendis Pharma A/S17B257.93$
13NBIXNEUROCRINE BIOSCIENCES INC17B166.05$
14BBIOBridgeBio Pharma, Inc.15B77.89$
15JAZZJazz Pharmaceuticals plc15B234.66$
16HALOHALOZYME THERAPEUTICS, INC.15B130.34$
17SMMTSummit Therapeutics Inc.13B16.17$
18KYMRKymera Therapeutics, Inc.12B136.25$
19TECHBIO-TECHNE Corp11B72.73$
20BMRNBIOMARIN PHARMACEUTICAL INC11B57.13$